InvestorsHub Logo
Followers 825
Posts 119428
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Wednesday, 11/18/2015 10:19:21 AM

Wednesday, November 18, 2015 10:19:21 AM

Post# of 442
FDA reviewing NVS’ 351(k) submission for Neulasta FoB: #msg-118583523.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMGN News